Takeda Pharmaceutical Company
Research Takeda Pharmaceutical Company (TAK) on Bullrun: market cap USD 59.20B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTAK
- ExchangeNYSE
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 59.20B
- Financial periodQ1 2027
- RevenueJPY 1.22T
- Net incomeJPY 113.20B
- Gross margin66.7%
Valuation Snapshot
latest market cap is USD 59.20B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 4.51T | -JPY 152.39B | JPY 626.77B | 65.1% | -48.38 | JPY 595.05B | JPY 4.88T | JPY 7.43T |
| FY2025 | JPY 4.58T | JPY 107.93B | JPY 677.56B | 65.5% | 33.62 | JPY 385.11B | JPY 4.52T | JPY 6.94T |
| FY2024 | JPY 4.26T | JPY 144.07B | JPY 235.61B | 66.5% | 45.58 | JPY 457.80B | JPY 4.84T | JPY 7.27T |
| FY2023 | JPY 4.03T | JPY 317.02B | JPY 343.47B | 69.1% | 100.97 | JPY 533.53B | JPY 4.38T | JPY 6.35T |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 59.20B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 49.24B | 65.0 | n/a | n/a |
| 2024 | 2024-12-31 | USD 41.98B | 30.8 | n/a | n/a |
| 2023 | 2023-12-29 | USD 44.78B | 32.4 | n/a | n/a |
| 2022 | 2022-12-30 | USD 48.50B | 29.4 | n/a | n/a |
| 2021 | 2021-12-31 | USD 42.46B | 10.6 | n/a | n/a |
About Takeda Pharmaceutical Company
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Takeda Pharmaceutical Company's market cap?
Takeda Pharmaceutical Company's market capitalization is USD 59.20B.
What does Takeda Pharmaceutical Company do?
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience.